Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy
Elevated SII and CA19-9 are independent prognostic markers for HCCA patients after surgery. The combination of high SII and high CA19-9 identifies a subgroup with the poorest prognosis, suggesting the potential for these markers to guide postoperative treatment decisions.
Authors
- Zhen You (ORCID: https://orcid.org/0000-0002-9792-7747)
- Sara Teresinha Olalla Saad (ORCID: https://orcid.org/0000-0003-0809-8068)
- Nan-Sheng Cheng (ORCID: https://orcid.org/0000-0002-3411-321X)
- Di Zeng
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3389/fonc.2025.1555369
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Sichuan University